晶泰控股-P今日盘中涨幅一度扩大至5.32%,引起了市场的广泛关注。
导致该股盘中大涨的主要原因如下:晶泰科技宣布与亚洲领先的韩国药企JW Pharmaceutical签署了一份千万级人民币的战略合作协议。根据该协议,晶泰科技将为JW提供药物发现的自动化工作站及基于人工智能的化学反应优化平台,以提升JW的药物研发效率、重复性和成功率。这无疑为晶泰科技增加了宝贵的海外药企客户订单,标志着其实验室自动化解决方案在海外市场进一步拓展,有助于提高公司的营收和利润。
另一方面,晶泰科技上月才完成了一次大规模的配股融资,成功募集超过11.3亿港元资金,金额更是超过其首次公开募股时的募资规模。充足的现金储备将有助于公司扩大业务版图,抓住行业发展机遇,被视为公司长期增长的利好因素。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.